51
|
Navarria P, Pessina F, Ascolese A, Cozzi L, Tomatis S, Riva M, Bello L, Clerici E, Lobefalo F, Scorsetti M. P13.11 Outcome evaluation of oligometastatic patients with single, large brain metastases treated with gross total resection (GTR) followed by hypofractionated stereotactic radiosurgery (HSRS) on the tumor bed. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now188.255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
52
|
Franzese C, Cozzi L, Clerici E, D'Agostino G, Navarria P, Comito T, De Rose F, Ascolese A, Franceschini D, Mancosu P, Tomatis S, Scorsetti M. Role of Stereotactic Body Radiation Therapy With Volumetric Modulated Arc Therapy Technique and FFF Beams for Abdomino-Pelvic Lymph Node Metastases in Oligometastatic Patients. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
53
|
Pessina F, Navarria P, Ascolese A, Cozzi L, Tomatis S, Riva M, Simonelli M, Scorsetti M, Bello L. P08.28 Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now188.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
54
|
Navarria P, Pessina F, Ascolese A, Tomatis S, Bello L, Simonelli M, Riva M, Lopci E, Santoro A, Scorsetti M. P08.44 Phase II study of hypofractionated radiation therapy with concomitant and adjuvant temozolomide following surgical resection for patients with newly diagnosed glioblastoma: preliminary evaluation. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now188.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
55
|
D'Agostino G, Franzese C, De Rose F, Franceschini D, Comito T, Villa E, Alongi F, Liardo R, Tomatis S, Navarria P, Mancosu P, Reggiori G, Cozzi L, Scorsetti M. High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. Clin Oncol (R Coll Radiol) 2016; 28:e173-e178. [PMID: 27389021 DOI: 10.1016/j.clon.2016.06.013] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2016] [Revised: 05/30/2016] [Accepted: 06/01/2016] [Indexed: 12/29/2022]
Abstract
AIMS The aim of this phase II study was to evaluate the efficacy and toxicity of stereotactic body radiotherapy in patients with low or intermediate risk prostate cancer. MATERIALS AND METHODS Biopsy-confirmed prostate cancer patients were enrolled, provided that they had the following characteristics: initial prostate-specific antigen (PSA) ≤ 20 ng/ml, Gleason Score < 7, International Prostate Symptom Score < 7. The treatment schedule was 35 Gy in five fractions, delivered with volumetric modulated arcs with flattening filter free beams. Toxicity was recorded according to CTCAE criteria v4.0. Biochemical failure was calculated according to the Phoenix definition. The Expanded Prostate Cancer Index Composite questionnaire was used to record health-related quality of life. RESULTS Between December 2011 and March 2015, 90 patients were enrolled (53 low risk, 37 intermediate risk). The median age was 71 years (range 48-82). In total, 58 (64.5%) of the patients had Gleason Score=6, the remaining had Gleason Score=7.The median initial PSA was 6.9 ng/ml (range 2.7-17.0). Acute toxicity was mild, with 32.2 patients presenting grade 1 urinary toxicity and 32.2% of patients presenting grade 2 urinary toxicity, mainly represented by urgency, dysuria and stranguria. Rectal grade 1 toxicity was found in 15.5% of patients, whereas grade 2 toxicity was recorded in 6.6% of patients. Regarding late toxicity, grade 1 proctitis was recorded in 11.1% of patients and grade 1 urinary in 38.8%; only two events of grade 2 urinary toxicity were observed (transient urethral stenosis, resolved by a 24 h catheterisation). At a median follow-up of 27 months (6-62 months) only two intermediate risk patients experienced a biochemical failure. Health-related quality of life revealed a slight worsening in all the domains during treatment, with a return to baseline 3 months after treatment. CONCLUSIONS Stereotactic body radiotherapy delivered using linac-based flattening filter free volumetric modulated arc radiotherapy in low and intermediate risk prostate cancer patients is associated with mild toxicity profiles and good patient-reported quality of life.
Collapse
|
56
|
Ascolese A, Franceschini D, De rose F, Cozzi L, Navarria P, Tozzi A, Iftode C, Villa E, Franzese C, Comito T, D'agostino G, Tomatis S, Liardo L, Scorsetti M. EP-1443: Radical hypofractionated VMAT-RA for stage III NSCLC in the elderly: feasibility and toxicity. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32693-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
57
|
Liu P, Reggiori G, Lobefalo F, Mancosu P, Tomatis S, McKenzie D, Suchowerska N. EP-1496: Small field correction factors for the IBA Razor. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32746-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
58
|
Reggiori G, Mancosu P, Stravato A, Lobefalo F, Paganini L, Zucconi F, Palumbo V, Suchowerska N, Tomatis S, Scorsetti M. EP-1517: Characterization of a new stereotactic diode under flattening filter free beams down to small fields. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32767-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
59
|
Comito T, Franzese C, Clerici E, De Rose F, Tozzi A, D'Agostino G, Navarria P, Iftode C, Villa E, Ascolese A, Franceschini D, Liardo R, Cozzi L, Foglliata A, Stravato A, Zucconi F, Reggiori G, Tomatis S, Scorsetti M. PO-0705: Clinical outcomes for inoperable HCC treated with SBRT: results on 71 patients and 102 lesions. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31955-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
60
|
Zucconi F, Mancosu P, Reggiori G, Lobefalo F, Stravato A, Gaudino A, Palumbo V, Paganini L, De Rose F, Tomatis S, Scorsetti M. PO-1009: VMAT planning approach to avoid superficial underdosage for accelerated partial breast irradiation. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32259-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
61
|
Clerici E, Comito T, Cozzi L, Fogliata A, Tozzi A, Iftode C, Franzese C, Navarria P, D'Agostino G, Mancosu P, Lobefalo F, Tomatis S, Scorsetti M. EP-1279: SABR in inoperable liver oligometastatic patients and radioresistant primary tumors. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32529-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
62
|
Reggiori G, Mancosu P, Suchowerska N, Lobefalo F, Stravato A, Tomatis S, Scorsetti M. Characterization of a new stereotactic diode under flattening filter free beams down to small fields. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
63
|
Nicolini G, Clivio A, Vanetti E, Tomatis S, Reggiori G, Cozzi L, Fogliata A. PO-0863: Dosimetric testing of the new aS1200 MV imager with FF and FFF beams. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40855-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
64
|
Mancosu P, Gaudino A, Lobefalo F, Maggi G, Navarria P, Palumbo V, Reggiori G, Stravato A, Scorsetti M, Tomatis S. PD-0469: Robustness study on pitch and roll rotations for multiple cranial metastases using VMAT. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40465-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
65
|
Tomatis S, Palumbo V, D'Agostino G, Maggi G, Gaudino A, Reggiori G, Lobefalo F, Stravato A, Mancosu P, Navarria P, Scorsetti M. EP-1329: Data mining applied to a radiotherapy department: developing quality assurance tools for risk management. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41321-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
66
|
Reggiori G, Lobefalo F, Gaudino A, Palumbo V, Scorsetti M, Stravato A, Tomatis S, Mancosu P. PO-0831: Characterization of an unshielded diode prototype for small field dosimetry under flattening filter free beams. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40823-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
67
|
Navarria P, Ascolese A, De Rose F, Clerici E, Franzese C, Tozzi A, Iftode C, Comito T, Villa E, Tomatis S, D'Agostino G, Reggiori G, Scorsetti M. PO-0668: Stereotactic Body Radiation Therapy (SBRT) for lung metastatic patients with soft tissue sarcoma (STS). Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40660-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
68
|
Gaudino A, Mancosu P, Lobefalo F, Maggi G, Palumbo V, Reggiori G, Scorsetti M, Stravato A, Tomatis S. OC-0077: Are pitch and roll compensations required in all pathologies? A data analysis of 2945 fractions. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40077-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
69
|
Stravato A, Reggiori G, Pimpinella M, Lobefalo F, Cozzi L, Fogliata A, Gaudino A, Mancosu P, Palumbo V, Scorsetti M, Tomatis S. PO-0827: Dosimetric characterization of PTW MicroDiamond for FFF beams and small fields: experimental and Monte Carlo study. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40819-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
70
|
De Rose F, Navarria P, Ascolese A, Comito T, Franzese C, Tozzi A, Clerici E, Iftode C, D'Agostino G, Villa E, Tomatis S, Cozzi L, Scorsetti M. EP-1177: SABR for lung lesions in NSCLC oligometastatic patients: toxicity and clinical outcomes. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41169-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
71
|
Lobefalo F, Fogliata A, Reggiori G, Stravato A, Cozzi L, Pimpinella M, Palumbo V, Mancosu P, Gaudino A, Scorsetti M, Tomatis S. PO-0821: Configuration of a treatment planning system: study and dosimetric evaluation for treatments with small fields. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40813-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
72
|
Zucca A, Mancosu P, Comito T, Lobefalo F, Galdieri C, Gaudino A, Modugno A, Palumbo V, Reggiori G, Stravato A, Tozzi A, Tomatis S, Scorsetti M. PO-1123 On line tracking of abdominal compression efficacy for pancreas SBRT by Calypso surface transponders. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41115-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
73
|
Scorsetti M, Comito T, Campisi M, Clerici E, Cozzi L, Tozzi A, Navarria P, Iftode C, Villa E, Mancosu P, Lobefalo F, Tomatis S. The Challenge of Inoperable Hepatocellular Carcinoma (HCC): Results of a Single-Institutional Experience on Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
74
|
Navarria P, Pessina F, Tomatis S, Mancosu P, Ascolese A, Lopci E, Bizzi A, Clerici E, Bello L, Scorsetti M. O2.02 * ROLE OF AN INTEGRATED IMAGING FOR TARGET VOLUME DEFINITION AND RADIOTHERAPY PLANNING IN PATIENTS WITH DIAGNOSED HIGH GRADE GLIOMA. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
75
|
Ascolese A, Pessina F, Navarria P, Tomatis S, Mancosu P, Clerici E, Bello L, Lobefalo F, Grimaldi M, Scorsetti M. P13.03 * HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HSR) IN RECURRENT HIGH GRADE GLIOMA: A SAFE AND EFFECTIVE APPROACH. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|